Format

Send to

Choose Destination
Curr Opin Microbiol. 2015 Oct;27:57-61. doi: 10.1016/j.mib.2015.07.005. Epub 2015 Aug 9.

Transferrin-mediated iron sequestration as a novel therapy for bacterial and fungal infections.

Author information

1
Department of Molecular Microbiology & Immunology, Keck School of Medicine at the University of Southern California (USC), Los Angeles, CA, United States. Electronic address: kbruhn@usc.edu.
2
Department of Medicine, Keck School of Medicine at USC, Los Angeles, United States.

Abstract

Pathogenic microbes must acquire essential nutrients, including iron, from the host in order to proliferate and cause infections. Iron sequestration is an ancient host antimicrobial strategy. Thus, enhancing iron sequestration is a promising, novel anti-infective strategy. Unfortunately, small molecule iron chelators have proven difficult to develop as anti-infective treatments, in part due to unacceptable toxicities. Iron sequestration in mammals is predominantly mediated by the transferrin family of iron-binding proteins. In this review, we explore the possibility of administering supraphysiological levels of exogenous transferrin as an iron sequestering therapy for infections, which could overcome some of the problems associated with small molecule chelation. Recent studies suggest that transferrin delivery may represent a promising approach to augment both natural resistance and traditional antibiotic therapy.

PMID:
26261881
PMCID:
PMC4659759
DOI:
10.1016/j.mib.2015.07.005
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center